OS Therapies Shares Jump on $6 Million Private Placement

Dow Jones

2024-12-24

By Dean Seal

Shares of OS Therapies climbed after the company said it has agreed to sell 1.5 million units to investors at $4 apiece in a private placement.

The stock was up 17.5% at $4.44 in early trading. Shares debuted at $4 in the company's initial public offering over the summer and have since vacillated between a high of $6.48 and a low of $1.58.

The clinical-stage biotechnology company said Tuesday that each of the units consists of one share of convertible preferred stock, which can be converted into one share of common stock and one warrant to buy another share.

The private placement is expected to yield proceeds of about $6 million, before offering-related costs, and close on Dec. 27.

Write to Dean Seal at dean.seal@wsj.com

(END) Dow Jones Newswires

December 24, 2024 10:02 ET (15:02 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2493080165"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2493080165\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2493080165?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-24 23:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2493080165","market":"sg","top_or_hot":-1,"title":"OS Therapies Shares Jump on $6 Million Private Placement","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Dean Seal \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of <a href=\"https://laohu8.com/S/OSTX\">OS Therapies</a> climbed after the company said it has agreed to sell 1.5 million units to investors at $4 apiece in a private placement. \n</p>\n<p>\n  The stock was up 17.5% at $4.44 in early trading. Shares debuted at $4 in the company's initial public offering over the summer and have since vacillated between a high of $6.48 and a low of $1.58. \n</p>\n<p>\n  The clinical-stage biotechnology company said Tuesday that each of the units consists of one share of convertible preferred stock, which can be converted into one share of common stock and one warrant to buy another share. \n</p>\n<p>\n  The private placement is expected to yield proceeds of about $6 million, before offering-related costs, and close on Dec. 27. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Dean Seal at dean.seal@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 24, 2024 10:02 ET (15:02 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>OS Therapies Shares Jump on $6 Million Private Placement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOS Therapies Shares Jump on $6 Million Private Placement\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2024-12-24 23:02</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Dean Seal \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of <a href=\"https://laohu8.com/S/OSTX\">OS Therapies</a> climbed after the company said it has agreed to sell 1.5 million units to investors at $4 apiece in a private placement. \n</p>\n<p>\n  The stock was up 17.5% at $4.44 in early trading. Shares debuted at $4 in the company's initial public offering over the summer and have since vacillated between a high of $6.48 and a low of $1.58. \n</p>\n<p>\n  The clinical-stage biotechnology company said Tuesday that each of the units consists of one share of convertible preferred stock, which can be converted into one share of common stock and one warrant to buy another share. \n</p>\n<p>\n  The private placement is expected to yield proceeds of about $6 million, before offering-related costs, and close on Dec. 27. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Dean Seal at dean.seal@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 24, 2024 10:02 ET (15:02 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2493080165","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2493080165","pubTimestamp":1735052520,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of OS Therapies climbed after the company said it has agreed to sell 1.5 million units to investors at $4 apiece in a private placement.The stock was up 17.5% at $4.44 in early trading. Shares debuted at $4 in the company's initial public offering over the summer and have since vacillated between a high of $6.48 and a low of $1.58.The clinical-stage biotechnology company said Tuesday that each of the units consists of one share of convertible preferred stock, which can be converted into one share of common stock and one warrant to buy another share.The private placement is expected to yield proceeds of about $6 million, before offering-related costs, and close on Dec. 27.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","OSTX":"OS Therapies"},"translate_title":"OS Therapies股价因600万美元私募而上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OSTX":1},"content_text":"By Dean Seal \n\n\n \n\n\n  Shares of OS Therapies climbed after the company said it has agreed to sell 1.5 million units to investors at $4 apiece in a private placement. \n\n\n  The stock was up 17.5% at $4.44 in early trading. Shares debuted at $4 in the company's initial public offering over the summer and have since vacillated between a high of $6.48 and a low of $1.58. \n\n\n  The clinical-stage biotechnology company said Tuesday that each of the units consists of one share of convertible preferred stock, which can be converted into one share of common stock and one warrant to buy another share. \n\n\n  The private placement is expected to yield proceeds of about $6 million, before offering-related costs, and close on Dec. 27. \n\n\n \n\n\n  Write to Dean Seal at dean.seal@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 24, 2024 10:02 ET (15:02 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1}}}